# Inactive HBsAg Carriers (IHCs) Treated With Pegylated Interferon α2b Based Intervention Therapy

> **NCT05451420** · NA · COMPLETED · sponsor: **Henan Provincial People's Hospital** · enrollment: 33 (actual)

## Conditions studied

- Chronic Hepatitis B

## Interventions

- **DRUG:** PegIFN α- 2b

## Key facts

- **NCT ID:** NCT05451420
- **Lead sponsor:** Henan Provincial People's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-01
- **Primary completion:** 2020-06-30
- **Final completion:** 2021-12-31
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2022-07-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05451420

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05451420, "Inactive HBsAg Carriers (IHCs) Treated With Pegylated Interferon α2b Based Intervention Therapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05451420. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*